Concepedia

Scott Kuhns

SK

Statistics

Publications

16

Citations

503

H-Index

12

Active since

1998

Affiliations

Amgen (United States)(Current)

Mayo Clinic

Scott Kuhns is an author at Amgen (United States) specializing in medicine, immunology, and natural sciences.

ORCID

Top concepts

Publications per year

1998–2023

16

Publications

16

Prevalent Class I-Restricted T-Cell Response to the Theiler’s Virus Epitope D<sup>b</sup>:VP2<sub>121–130</sub>in the Absence of Endogenous CD4 Help, Tumor Necrosis Factor Alpha, Gamma Interferon, Perforin, or Costimulation through CD28

Aaron J. Johnson, M. Kariuki Njenga, Michael J. Hansen et al. · Journal of Virology · 1999 · 115 citations · Full text

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

Jennifer Liu, Tamer Eris, Cynthia Li et al. · BioDrugs · 2016 · 97 citations · Full text

Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab

Neung‐Seon Seo, Alla Polozova, Mingxuan Zhang et al. · mAbs · 2018 · 81 citations · Full text

, , +18

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Katariina M. Hutterer, Alla Polozova, Scott Kuhns et al. · BioDrugs · 2019 · 29 citations · Full text

A Region of Conformational Variability Outside the Peptide-Binding Site of a Class I MHC Molecule

Scott Kuhns, Larry R. Pease · The Journal of Immunology · 1998 · 25 citations · Full text

, , +21

1–5 of 16